This is a $1,647,593 firm-fixed-price delivery order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University of New Jersey. The award is for the NIDA Center for Genetic Studies, where Rutgers will receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023 to March 2028. This delivery order provides $1.6 million...
This is a firm fixed-price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The $2,499,626.17 contract is for the NIDA Center for Genetic Studies, providing services such as receiving, processing, storing, and distributing de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023...
This is a delivery order under a $15 million Indefinite Delivery Contract (IDC) awarded by the National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The task order, valued at $2,807,643, is for the NIDA Center for Genetic Studies, which Rutgers operates to receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. This supports NIDA's research objectives on genetic factors related to substance...
Rutgers, The State University of New Jersey was awarded a $2.5 million firm fixed-price delivery order against the National Institutes of Health National Institute on Drug Abuse's Center for Genetic Studies indefinite delivery/indefinite quantity contract. Under the one-year task order, Rutgers will provide research services in support of NIDA's mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health....
The National Institute on Drug Abuse (NIDA) Center for Genetic Studies awarded a $2.5 million firm fixed price delivery order contract to Rutgers, The State University Research Financial Services Division for the period of March 14, 2022 through March 13, 2023. As the prime contractor, Rutgers, The State University Research Financial Services Division will provide research services in support of NIDA's Center for Genetic Studies, with performance taking place in New Brunswick, New Jersey.
This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University to establish and operate the NIDA Center for Genetic Studies. The contract is a single-award Indefinite Delivery Contract valued at $2,144,869.96 to support the continued genetic research services for the Center between September 2019 and September 2022, with a potential extension through March 2028. The contract is not designated as a set-aside. As the...
This contract award is for the NIDA Center for Genetic Studies, which is a single-award Indefinite Delivery Contract from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Rutgers, The State University, through its Research Financial Services Division. The contract is for the establishment and operation of the NIDA Center for Genetic Studies, which involves receiving, processing, storing and...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a firm-fixed-price purchase order contract to Rutgers, The State University in the amount of $16,820.23. The contract, which has a completion date of June 30, 2025, is for the provision of custom mouse model CRISPR gene editing services. Rutgers, a major public research institution and 1862 land grant university, will leverage its expertise...
This federal contract award is for the creation of induced pluripotent stem cells, awarded by the National Institute on Drug Abuse, a civilian agency, to Rutgers, The State University. The $68,042.40 firm fixed-price purchase order was awarded on September 16, 2020, with a completion date of September 20, 2021. The contract is not set aside for any particular business type. Rutgers is a major public research university and a prominent land-grant institution, with extensive capabilities in...
This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services. The $300,216 Firm Fixed Price contract was awarded to Rutgers, The State University to support "Computational Thinking to Support Clinicians and Biomedical Scientists". This work was funded through the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation....
This is a firm-fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), an agency within the Department of Health and Human Services, to Rutgers, The State University of New Jersey. The contract, valued at $1,982,526.92, is for the NIDA Adolescent Brain Cognitive Development (ABCD) Study Genome Center and Biospecimens Repository. Rutgers, through its Research Financial Services Division, will receive, process, store, and distribute de-identified clinical data and biospecimens in support of NIDA's research on genetic factors related to substance use disorders. This delivery order is part of a larger $15 million Indefinite Delivery Contract (IDC) awarded by NIDA to Rutgers to operate the NIDA Center for Genetic Studies, with a period of performance through 2028. The contract does not have a set-aside designation.